Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy
Guido Moll, Norman Michael Drzeniek, Julian Kamhieh‐Milz, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 156

Showing 1-25 of 156 citing articles:

Fair Allocation of Scarce Medical Resources in the Time of Covid-19
Ezekiel Emanuel, Govind Persad, Ross Upshur, et al.
New England Journal of Medicine (2020) Vol. 382, Iss. 21, pp. 2049-2055
Open Access | Times Cited: 2996
Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases
Cynthia M. Magro, J. Justin Mulvey, David Berlin, et al.
Translational research (2020) Vol. 220, pp. 1-13
Open Access | Times Cited: 2177
Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy
Giacomo Grasselli, Antonio Artigas, Maurizio Cecconi
JAMA (2020) Vol. 323, Iss. 16, pp. 1545-1545
Open Access | Times Cited: 2014
SARS-CoV-2: a storm is raging
Savannah F. Pedersen, Ya‐Chi Ho
Journal of Clinical Investigation (2020) Vol. 130, Iss. 5, pp. 2202-2205
Open Access | Times Cited: 1171
Challenges and advances in clinical applications of mesenchymal stromal cells
Tian Zhou, Zenan Yuan, Jianyu Weng, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 463
Mesenchymal stromal cell therapies: immunomodulatory properties and clinical progress
Xiaomo Wu, Ju Jiang, Zhongkai Gu, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 236
A Brief Overview of Global Trends in MSC-Based Cell Therapy
Dragomirka Jovic, Yingjia Yu, Dan Wang, et al.
Stem Cell Reviews and Reports (2022) Vol. 18, Iss. 5, pp. 1525-1545
Open Access | Times Cited: 166
Umbilical Cord Mesenchymal Stromal Cells as Critical COVID-19 Adjuvant Therapy: A Randomized Controlled Trial
Ismail Hadisoebroto Dilogo, Dita Aditianingsih, Adhrie Sugiarto, et al.
Stem Cells Translational Medicine (2021) Vol. 10, Iss. 9, pp. 1279-1287
Open Access | Times Cited: 142
Immunomodulatory Properties of Mesenchymal Stromal Cells: An Update
Luise Müller, Antje Tunger, Manja Wobus, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 128
The Therapeutic Potential of Mesenchymal Stromal Cells for Regenerative Medicine: Current Knowledge and Future Understandings
Makram Merimi, Rania El-Majzoub, Laurence Lagneaux, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 125
Evaluation of the safety and efficacy of using human menstrual blood‐derived mesenchymal stromal cells in treating severe and critically ill COVID‐19 patients: An exploratory clinical trial
Xiaowei Xu, Wanli Jiang, Lijun Chen, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 2
Open Access | Times Cited: 112
Improved MSC Minimal Criteria to Maximize Patient Safety: A Call to Embrace Tissue Factor and Hemocompatibility Assessment of MSC Products
Guido Moll, James A. Ankrum, Scott D. Olson, et al.
Stem Cells Translational Medicine (2022) Vol. 11, Iss. 1, pp. 2-13
Open Access | Times Cited: 111
Impact of Cryopreservation and Freeze-Thawing on Therapeutic Properties of Mesenchymal Stromal/Stem Cells and Other Common Cellular Therapeutics
Chasen Cottle, Amanda Paige Porter, Ariel Joy Lipat, et al.
Current Stem Cell Reports (2022) Vol. 8, Iss. 2, pp. 72-92
Open Access | Times Cited: 86
Adverse events, side effects and complications in mesenchymal stromal cell-based therapies
Denis Baranovskii, Ilya Klabukov, Nadezhda V. Arguchinskaya, et al.
Stem Cell Investigation (2022) Vol. 9, pp. 7-7
Open Access | Times Cited: 78
Calming the Storm: Natural Immunosuppressants as Adjuvants to Target the Cytokine Storm in COVID-19
Angela E. Peter, B. V. Sandeep, B. Ganga Rao, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 84
Mesenchymal Stromal Cells for Enhancing Hematopoietic Engraftment and Treatment of Graft-Versus-Host Disease, Hemorrhages and Acute Respiratory Distress Syndrome
Olle Ringdén, Guido Moll, Britt Gustafsson, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 59
Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury
Claúdia C. dos Santos, Hajera Amatullah, Chirag M. Vaswani, et al.
European Respiratory Journal (2021) Vol. 59, Iss. 1, pp. 2004216-2004216
Open Access | Times Cited: 56
The Epidermal Keratinocyte as a Therapeutic Target for Management of Diabetic Wounds
Wei‐Cheng Fang, Cheng‐Che E. Lan
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4290-4290
Open Access | Times Cited: 27
Perinatal tissue-derived exosomes ameliorate colitis in mice by regulating the Foxp3 + Treg cells and gut microbiota
Yaping Yan, Kaixiu Li, Jiang Jiang, et al.
Stem Cell Research & Therapy (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach
Dennyson Leandro M. Fonseca, Igor Salerno Filgueiras, Alexandre H. C. Marques, et al.
npj Aging (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 24
Fighting cytokine storm and immunomodulatory deficiency: By using natural products therapy up to now
Mona A. Mohammed
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 23
The role of mesenchymal stromal cells in immune modulation of COVID-19: focus on cytokine storm
Maria Kavianpour, Mahshid Saleh, Javad Verdi
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 70
Mesenchymal stem cell therapies for COVID-19: Current status and mechanism of action
Somayeh Sadeghi, Sara Soudi, Abbas Shafiee, et al.
Life Sciences (2020) Vol. 262, pp. 118493-118493
Open Access | Times Cited: 51
COVID‐19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?
Philip W. Askenase
Journal of Extracellular Vesicles (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 51
The contributory role of lymphocyte subsets, pathophysiology of lymphopenia and its implication as prognostic and therapeutic opportunity in COVID-19
Mahda Delshad, Naeimeh Tavakolinia, Atieh Pourbagheri‐Sigaroodi, et al.
International Immunopharmacology (2021) Vol. 95, pp. 107586-107586
Open Access | Times Cited: 42
Page 1 - Next Page

Scroll to top